<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Ceradyne (CRDN) Sensitivity Analysis</title>
	<atom:link href="http://stockmarketbeat.com/blog1/2006/05/17/ceradyne-crdn-sensitivity-analysis/feed/" rel="self" type="application/rss+xml" />
	<link>http://stockmarketbeat.com/blog1/2006/05/17/ceradyne-crdn-sensitivity-analysis/</link>
	<description>Our beat: The stock market. Our job: Beat it.</description>
	<lastBuildDate>Tue, 03 Jun 2008 15:36:49 -0600</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.1</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Sensitivity Analysis - Financial Education - Everything You Need To Know About Finance</title>
		<link>http://stockmarketbeat.com/blog1/2006/05/17/ceradyne-crdn-sensitivity-analysis/comment-page-1/#comment-20055</link>
		<dc:creator>Sensitivity Analysis - Financial Education - Everything You Need To Know About Finance</dc:creator>
		<pubDate>Thu, 15 Mar 2007 19:05:14 +0000</pubDate>
		<guid isPermaLink="false">http://stockmarketbeat.com/blog1/2006/05/17/ceradyne-crdn-sensitivity-analysis/#comment-20055</guid>
		<description>[...] When investors are unsure about a company&#8217;s prospects and want to evaluate them under a variety of circumstances, it can be useful to perform a sensitivity or scenario analysis. One example of such an analysis was originally published at Stock Market Beat, and is reprinted here with the author&#8217;s permission. [...]</description>
		<content:encoded><![CDATA[<p>[...] When investors are unsure about a company&#8217;s prospects and want to evaluate them under a variety of circumstances, it can be useful to perform a sensitivity or scenario analysis. One example of such an analysis was originally published at Stock Market Beat, and is reprinted here with the author&#8217;s permission. [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Ceradyne&#8217;s (CRDN) Good News is No News - Stock Market Beat - Our beat is the stock market. Our job is to beat it.</title>
		<link>http://stockmarketbeat.com/blog1/2006/05/17/ceradyne-crdn-sensitivity-analysis/comment-page-1/#comment-10482</link>
		<dc:creator>Ceradyne&#8217;s (CRDN) Good News is No News - Stock Market Beat - Our beat is the stock market. Our job is to beat it.</dc:creator>
		<pubDate>Thu, 11 Jan 2007 15:12:40 +0000</pubDate>
		<guid isPermaLink="false">http://stockmarketbeat.com/blog1/2006/05/17/ceradyne-crdn-sensitivity-analysis/#comment-10482</guid>
		<description>[...] While the news has lifted the shares this morning, it will be more interesting to see what the company predicts for 2007 when they hold their conference call in late February. So far the company has not only beaten consensus estimates but even the most wildly bullish ones. However, we are still concerned that military body armor orders are peaking and the leverage will work both ways. [...]</description>
		<content:encoded><![CDATA[<p>[...] While the news has lifted the shares this morning, it will be more interesting to see what the company predicts for 2007 when they hold their conference call in late February. So far the company has not only beaten consensus estimates but even the most wildly bullish ones. However, we are still concerned that military body armor orders are peaking and the leverage will work both ways. [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

